APA (7th ed.) Citation

Eldfors, S., Kuusanmäki, H., Kontro, M., Majumder, M., Parsons, A., Edgren, H., . . . Heckman, C. (2016). 612 - Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia. European Journal of Cancer, 61, S136. https://doi.org/10.1016/S0959-8049(16)61481-8

Chicago Style (17th ed.) Citation

Eldfors, S., et al. "612 - Idelalisib Sensitivity and Mechanisms of Disease Progression in Relapsed TCF3-PBX1 Acute Lymphoblastic Leukemia." European Journal of Cancer 61 (2016): S136. https://doi.org/10.1016/S0959-8049(16)61481-8.

MLA (9th ed.) Citation

Eldfors, S., et al. "612 - Idelalisib Sensitivity and Mechanisms of Disease Progression in Relapsed TCF3-PBX1 Acute Lymphoblastic Leukemia." European Journal of Cancer, vol. 61, 2016, p. S136, https://doi.org/10.1016/S0959-8049(16)61481-8.